Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs

References

• Carrasco-Portino M, Ruiz Cantero MT, Fernandez Saez J, Clemente Gomez V, Roca Perez V. Geopolitical development inequalities in gender in Spain 1980–2005: a structural determinant of health]. Rev Esp Salud Publica. 2010; 84: 13–28. [PubMed Abstract].
   Google Scholar
• Ley Orgánica 3/2007, de 22 de marzo, para la igualdad efectiva de mujeres y hombres. Boletín Oficial del Estado Núm. 88.
   Google Scholar
• Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la Innovación. Boletín del estado num 131.
   Google Scholar
• LaRosa J, Pinn VW. Gender bias in biomedical research. J Am Med Womens Assoc. 1993; 48: 145–51. [PubMed Abstract].
   Google Scholar
• Ruiz M, Verbrugge L. A two way view of gender bias in medicine. J Epidemiol Community Health. 1997; 51: 106–9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ruiz-Cantero MT, Vives-Cases C, Artazcoz L, Delgado A, García Calvente Md M, Miqueo C, etal. A framework to analyse gender bias in epidemiological research. J Epidemiol Community Health. 2007; 61(Suppl 2): ii46–53. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cambronero Saiz B, Ruiz Cantero MT, Papi Galvez N. Quality of pharmaceutical advertising and gender bias in medical journals (1998–2008): a review of the scientific literature. Gac Sanit. 2012; 26: 469–76. [PubMed Abstract].
   Google Scholar
• Lippman A. The inclusion of women in clinical trials: are we asking the right questions?. Women and Health Protection. 2006. Available from: http://www.whp-apsf.ca/pdf/clinicalTrialsEN.pdf#sthash.NfPoVx0L.dpuf [cited 30 June 2014]..
   Google Scholar
• Herz S. Don't test, do sell: legal implications of inclusion of women in clinical drug trials. Epilepsia. 1997; 38(Suppl 4): S42–9. [PubMed Abstract].
   Google Scholar
• Merkatz RB, Junod SW. Historical background of changes in FDA policy on the study and evaluation of drugs in women. Acad Med. 1994; 69: 703–7. [PubMed Abstract].
   Google Scholar
• Food and Drug Administration. General considerations for the clinical evaluation of drugs. 1977; Washington, DC: FDA.
   Google Scholar
• National Institutes of Health. NIH guide for grants and contracts. 1986; Bethesda, USA: Inclusion of women in study populations.
   Google Scholar
• General Accounting Office. Problems in implementing policy on women in study populations. GAO/HRD-90-38. 1990; Bethesda, MD: National Institutes of Health.
   Google Scholar
• Food and Drug Administration Department of Health and Human Services of FDA. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs. 1993; Rockville, USA: Federal Register. 39409–11.
   Google Scholar
• National Institutes of Health (NIH). Revitalization Act, Subtitle B, Part 1, Sec. 1993; 131–3.
   Google Scholar
• International Conference on Harmonisation (ICH). Gender considerations in the conduct of clinical trials. EMEA/CHMP/3916/2005-ICH. European Medicines Agency. Available from: http://www.ich.org/products/consideration-documents.html [cited 30 June 2014]..
   Google Scholar
• Ruiz Cantero MT, Angeles Pardo M. European Medicines Agency policies for clinical trials leave women unprotected. J Epidemiol Community Health. 2006; 60: 911–13. [PubMed Abstract].
   Google Scholar
• Stephenson P, McKee M. Look twice. Eur J Publ Health. 1993; 3: 151–2.
   Google Scholar
• Nandi S, Guzman R, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA. 1995; 92: 3650–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Auchincloss H, Haagensen CD. Cancer of the breast possibly induced by estrogenic substance. JAMA. 1940; 114: 1517–23.
   Google Scholar
• Gusberg SB. Precursors of corpus carcinoma estrogens and adenomatous hyperplasia. Obstet Gynecol Surv. 1948; 3: 419–21.
   Google Scholar
• Kopera H. The dawn of hormone replacement therapy. Maturitas. 1991; 13: 187–8. [PubMed Abstract].
   Google Scholar
• Ettinger B. Overview of estrogen replacement therapy: a historical perspective. Proc Soc Exp Biol Med. 1998; 217: 2–5. [PubMed Abstract].
   Google Scholar
• Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975; 293: 1164–7. [PubMed Abstract].
   Google Scholar
• Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975; 293: 1167–70. [PubMed Abstract].
   Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg CL, Stefanick ML, etal. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321–33. [PubMed Abstract].
   Google Scholar
• Agencia Española del Medicamenteo y Productos Sanitarios. Restricción de las indicaciones terapéuticas de la Terapia Hormonal Sustitutiva en la Menopausia [Restriction of the therapeutic indications of hormone replacement therapy in menopause]. 2004. Available from: http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2004/NI_2004-01_THS_restriccion.htm [cited 30 June 2014]..
   Google Scholar
• Agencia Española del Medicamento. Terapia Hormonal Sustitutiv en la Menopausia. Actualizando información. 2008. Available from: http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2008/NI_2008-16_terapia_hormonal.htm [cited 30 June 2014]..
   Google Scholar
• Krieger N, Löwy I, Aronowitz R, Bigby J, Dickersin K, Garner E, etal. Hormone replacement therapy, cancer, controversies and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health. 2005; 59: 740–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mintzes B. Disease mongering in drug promotion: do governments have a regulatory role?. PLoS Med. 2006; 3: e198. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Olson MK. Are novel drugs more risky for patients than less novel drugs?. J Health Econ. 2004; 23: 1135–58. [PubMed Abstract].
   Google Scholar
• Muir Gray J. Canadian clinicians and patients need clean, clear knowledge. Can Med Assoc J. 2004; 175: 129.
   Web of Science ®Google Scholar
• Commission of the European Communities (Brussels). eEurope 2002: quality criteria for health related websites. J Med Internet Res. 2002; 4: 15.
   Web of Science ®Google Scholar
• Eysenbach G, Köhler C. Health-related searches on the internet. JAMA. 2004; 291: 2946. [PubMed Abstract].
   Google Scholar
• Hardey M. ‘E-health’: the internet and the transformation of patients into consumers and producers of health knowledge. Inform Comm Soc. 2001; 4: 388–405.
   Google Scholar
• Inhorn MC, Whittle KL. Feminism meets the “new” epidemiologies: toward an appraisal of antifeminist biases in epidemiological research on women's health. Soc Sci Med. 2001; 53: 553–67. [PubMed Abstract].
   Google Scholar
• Krieger N, Zierler S. Accounting for health of women. Crit Publ Health. 1997; 7: 38–49.
   Google Scholar
• Friedan B. La mística de la feminidad. 1974; Madrid: Jucar.
   Google Scholar
• Ashton H. Psychotropic-drug prescribing for women. Br J Psychiatry. 1991; 10(Suppl): 30–5.
   Web of Science ®Google Scholar
• Colameco S, Becker L, Simpson M. Sex bias in the assessment of patients complaints. J Fam Pract. 1983; 16: 1117–21. [PubMed Abstract].
   Google Scholar
• Graham H. Gender and class as dimensions of smoking behaviour in Britain: insights from a survey of mothers. Soc Sci Med. 1994; 38: 691–8. [PubMed Abstract].
   Google Scholar
• Krieger N. Genders, sexes, and health: what are the connections and why does it matter?. Int J Epidemiol. 2003; 32: 652–7. [PubMed Abstract].
   Google Scholar
• Healy B. The Yentl syndrome. N Engl J Med. 1991; 325: 274–6. [PubMed Abstract].
   Google Scholar
• Kawachi I, Kennedy B, Gupta V, Prothow-Stith D. Women's status and the health of women and men. Soc Sci Med. 1999; 48: 21–32. [PubMed Abstract].
   Google Scholar
• Varkey P, Kureshi S, Lesnick T. Empowerment of women and its association with the health of the community. J Womens Health. 2010; 19: 71–6.
   PubMed Web of Science ®Google Scholar
• Hambwerg K, Risberg G, Johansson E, Westman G. Gender bias in physicians management of neck pain: a study of the answers in a Swedish national examination. J Womens Health Gend Based Med. 2002; 11: 653–66.
   PubMedGoogle Scholar
• Malterud K. Symptoms as a source of medical knowledge: understanding medically unexplained disorders in women. Fam Med. 2000; 32: 603–11. [PubMed Abstract].
   Google Scholar
• Hirsh AT, George SZ, Robinson ME. Pain assessment and treatment disparities: a virtual human technology investigation. Pain. 2009; 143: 106–13. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chilet-Rosell E, Ruiz-Cantero MT, Horga JF. Women's health and gender-based clinical trials on etoricoxib: methodological gender bias. J Public Health. 2009; 31: 434–45.
   Web of Science ®Google Scholar
• Chilet Rosell E, Ruiz Cantero MT, Laguna-Goya N, De Andres Rodriguez-Trelles F. Recommendations for the study and evaluation of gender differences in clinical trials in Spain]. Med Clin (Barc). 2010; 135: 130–4. [PubMed Abstract].
   Google Scholar
• Rodríguez LAG, Patrignani P. The ever growing story of cyclo-oxygenase inhibition. Lancet. 2006; 368: 1745–7.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. 2005; Etoricoxib: summary of product characteristics (SPC), CHMP/EMEA. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Etoricoxib_2004_31/WC500013654.pdf [cited 30 June 2014]..
   Google Scholar
• Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkley KJ, Fillingim RB, etal. Studying sex and gender differences in pain and analgesia: a consensus report. Pain. 2007; 132(Suppl 1): S26–45. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chilet-Rosell E, Martin Llaguno M, Ruiz Cantero MT, Alonso-Coello P. Hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain. BMC Public Health. 2010; 10: 134. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chilet-Rosell E, Ruiz-Cantero MT, Saez JF, Alvarez-Dardet C. Inequality in analgesic prescription in Spain. A gender development issue. Gac Sanit. 2013; 27: 135–42. [PubMed Abstract].
   Google Scholar
• Simon V. Wanted: women in clinical trials. Science. 2005; 308: 1517. [PubMed Abstract].
   Google Scholar
• Merck. Annual Report 2007. Available from: Available from: http://www.merck.com/newsroom/pdf/4q07_financial_results.pdf [cited 30 June 2014]..
   Google Scholar
• Hawkins JW, Aber CS. Women in advertisements in medical journals. Sex Roles. 1993; 28: 233–42.
   Web of Science ®Google Scholar
• Riska E, Heikell T. Gender and images of heart disease in Scandinavian drug advertising. Scand J Publ Health. 2007; 35: 585–90.
   PubMed Web of Science ®Google Scholar
• Curry P, O'Brien M. The male heart and the female mind: a study in the gendering of antidepressants and cardiovascular drugs in advertisements in Irish medical publication. Soc Sci Med. 2006; 62: 1970–7. [PubMed Abstract].
   Google Scholar
• Ministerio de Sanidad y Política Social. Avanzando hacia la equidad. Propuesta de políticas e intervenciones para reducir las desigualdades de salud en España. Available from: http://www.msc.es/profesionales/saludPublica/prevPromocion/promocion/desigualdadSalud/docs/Propuesta_Politicas_Reducir_Desigualdades.pdf [cited 4 June 2012]..
   Google Scholar
• Whitehead M. The concepts and principles of equity and health. 1990; Copenhagen: WHO Regional Office for Europe.
   Google Scholar
• United Nations. Report of the fourth World Conference on Women, Beijing declaration and platform for action. 1995; New York: United Nations.
   Google Scholar
• Torsheim T, Ravens-Sieberer U, Hetland J, Välima R, Danielson M, Overpeck M. Cross-national variation of gender differences in adolescent subjective health in Europe and North America. Soc Sci Med. 2006; 62: 815–57. [PubMed Abstract].
   Google Scholar
• Storla DG, Yimer S, Bjune G. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008; 8: 15. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Stanford University. Gendered innovations. Available from: http://genderedinnovations.stanford.edu/ [cited 22 September 2014]..
   Google Scholar